Global Intravenous Solutions (Colloids) Competitive Landscape Professional Research Report 2024

Global Intravenous Solutions (Colloids) Competitive Landscape Professional Research Report 2024



Research Summary

Intravenous solutions containing colloids are sterile liquid preparations administered directly into the veins for therapeutic purposes. Unlike crystalloid solutions, which primarily consist of electrolytes and water, colloids contain larger particles, often in the form of proteins or synthetic substances, that remain suspended in the solution. These colloidal solutions are used to address conditions where there is a need to increase the oncotic pressure within the blood vessels or to support plasma volume expansion. Albumin and synthetic colloids like hydroxyethyl starch are examples of colloidal solutions frequently used in intravenous therapy. Colloids help to retain fluid within the blood vessels and can be employed in situations such as hypovolemic shock, severe burns, or major surgeries where maintaining adequate intravascular volume is crucial. The use of intravenous colloids requires careful consideration of the patient's medical condition, and their administration is typically under medical supervision to ensure appropriate dosage and monitoring for potential side effects.

According to DIResearch's in-depth investigation and research, the global Intravenous Solutions (Colloids) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Intravenous Solutions (Colloids) include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, Amanta Healthcare, Grifols S.A., Terumo Medical Corporation etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Intravenous Solutions (Colloids). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravenous Solutions (Colloids) market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Intravenous Solutions (Colloids) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravenous Solutions (Colloids) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Intravenous Solutions (Colloids) Include:

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Grifols S.A.

Terumo Medical Corporation

Intravenous Solutions (Colloids) Product Segment Include:

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Intravenous Solutions (Colloids) Product Application Include:

Hospital and Clinics

Ambulatory

Home Care

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Intravenous Solutions (Colloids) Industry PESTEL Analysis

Chapter 3: Global Intravenous Solutions (Colloids) Industry Porter’s Five Forces Analysis

Chapter 4: Global Intravenous Solutions (Colloids) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Intravenous Solutions (Colloids) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Intravenous Solutions (Colloids) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Intravenous Solutions (Colloids) Market Overview
1.1 Product Definition and Statistical Scope
1.2 Intravenous Solutions (Colloids) Product by Type
1.2.1 Global Intravenous Solutions (Colloids) Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Solutions (Colloids) Product by Application
1.3.1 Global Intravenous Solutions (Colloids) Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global Intravenous Solutions (Colloids) Market Revenue and Sales Analysis
1.4.1 Global Intravenous Solutions (Colloids) Market Size Analysis (2019-2030)
1.4.2 Global Intravenous Solutions (Colloids) Market Sales Analysis (2019-2030)
1.4.3 Global Intravenous Solutions (Colloids) Market Sales Price Trend Analysis (2019-2030)
1.5 Intravenous Solutions (Colloids) Market Development Status and Trends
1.5.1 Intravenous Solutions (Colloids) Industry Development Status Analysis
1.5.2 Intravenous Solutions (Colloids) Industry Development Trends Analysis
2 Intravenous Solutions (Colloids) Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Intravenous Solutions (Colloids) Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Intravenous Solutions (Colloids) Market Analysis by Regions
4.1 Intravenous Solutions (Colloids) Overall Market: 2023 VS 2024 VS 2030
4.2 Global Intravenous Solutions (Colloids) Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Intravenous Solutions (Colloids) Revenue and Market Share by Region (2019-2024)
4.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Region (2025-2030)
4.3 Global Intravenous Solutions (Colloids) Sales and Forecast Analysis (2019-2030)
4.3.1 Global Intravenous Solutions (Colloids) Sales and Market Share by Region (2019-2024)
4.3.2 Global Intravenous Solutions (Colloids) Sales Forecast by Region (2025-2030)
4.4 Global Intravenous Solutions (Colloids) Sales Price Trend Analysis (2019-2030)
5 Global Intravenous Solutions (Colloids) Market Size by Type and Application
5.1 Global Intravenous Solutions (Colloids) Market Size by Type
5.1.1 Global Intravenous Solutions (Colloids) Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Intravenous Solutions (Colloids) Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Intravenous Solutions (Colloids) Market Size by Application
5.2.1 Global Intravenous Solutions (Colloids) Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Intravenous Solutions (Colloids) Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Intravenous Solutions (Colloids) Market Size by Type
6.3.1 North America Intravenous Solutions (Colloids) Sales by Type (2019-2030)
6.3.2 North America Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
6.4 North America Intravenous Solutions (Colloids) Market Size by Application
6.4.1 North America Intravenous Solutions (Colloids) Sales by Application (2019-2030)
6.4.2 North America Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
6.5 North America Intravenous Solutions (Colloids) Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Intravenous Solutions (Colloids) Market Size by Type
7.3.1 Europe Intravenous Solutions (Colloids) Sales by Type (2019-2030)
7.3.2 Europe Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
7.4 Europe Intravenous Solutions (Colloids) Market Size by Application
7.4.1 Europe Intravenous Solutions (Colloids) Sales by Application (2019-2030)
7.4.2  Europe Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
7.5 Europe Intravenous Solutions (Colloids) Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Intravenous Solutions (Colloids) Market Size by Type
8.3.1 China Intravenous Solutions (Colloids) Sales by Type (2019-2030)
8.3.2 China Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
8.4 China Intravenous Solutions (Colloids) Market Size by Application
8.4.1 China Intravenous Solutions (Colloids) Sales by Application (2019-2030)
8.4.2 China Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Intravenous Solutions (Colloids) Market Size by Type
9.3.1 APAC (excl. China) Intravenous Solutions (Colloids) Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
9.4 APAC (excl. China) Intravenous Solutions (Colloids) Market Size by Application
9.4.1 APAC (excl. China) Intravenous Solutions (Colloids) Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
9.5 APAC (excl. China) Intravenous Solutions (Colloids) Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Intravenous Solutions (Colloids) Market Size by Type
10.3.1 Latin America Intravenous Solutions (Colloids) Sales by Type (2019-2030)
10.3.2 Latin America Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
10.4 Latin America Intravenous Solutions (Colloids) Market Size by Application
10.4.1 Latin America Intravenous Solutions (Colloids) Sales by Application (2019-2030)
10.4.2 Latin America Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
10.5 Latin America Intravenous Solutions (Colloids) Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Type
11.3.1 Middle East & Africa Intravenous Solutions (Colloids) Sales by Type (2019-2030)
11.3.2 Middle East & Africa Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
11.4 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Application
11.4.1 Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2019-2030)
11.4.2 Middle East & Africa Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
11.5 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Intravenous Solutions (Colloids) Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Intravenous Solutions (Colloids) Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Intravenous Solutions (Colloids) Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Intravenous Solutions (Colloids) Average Sales Price by Manufacturers (2020-2024)
12.2 Intravenous Solutions (Colloids) Competitive Landscape Analysis and Market Dynamic
12.2.1 Intravenous Solutions (Colloids) Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 ICU Medical Inc.
13.1.1 ICU Medical Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
13.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 B. Braun Melsungen AG
13.2.1 B. Braun Melsungen AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
13.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Fresenius Kabi AG
13.3.1 Fresenius Kabi AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
13.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.4 Baxter
13.4.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Baxter Intravenous Solutions (Colloids) Product Portfolio
13.4.3 Baxter Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.5 Amanta Healthcare
13.5.1 Amanta Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
13.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.6 Grifols S.A.
13.6.1 Grifols S.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
13.6.3 Grifols S.A. Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.7 Terumo Medical Corporation
13.7.1 Terumo Medical Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
13.7.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Intravenous Solutions (Colloids) Industry Chain Analysis
14.2 Intravenous Solutions (Colloids) Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Intravenous Solutions (Colloids) Typical Downstream Customers
14.4 Intravenous Solutions (Colloids) Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings